159 related articles for article (PubMed ID: 24122711)
1. Effect of the oral intake of probiotic Pediococcus acidilactici BA28 on Helicobacter pylori causing peptic ulcer in C57BL/6 mice models.
Kaur B; Garg N; Sachdev A; Kumar B
Appl Biochem Biotechnol; 2014 Jan; 172(2):973-83. PubMed ID: 24122711
[TBL] [Abstract][Full Text] [Related]
2. Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice model.
Lee M; Chung JY; Kim KY; Im W; Kim M
BMC Microbiol; 2020 Dec; 20(1):372. PubMed ID: 33297964
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of Lactobacillus acidophilus on Helicobacter pylori in peptic ulcer patients: in vitro study.
Vilaichone RK; Mahachai V; Tumwasorn S; Nunthapisud P; Kullavanijaya P
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S79-84. PubMed ID: 12188456
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori. Its role in the pathogenesis of peptic ulcer disease in a new animal model.
Ross JS; Bui HX; del Rosario A; Sonbati H; George M; Lee CY
Am J Pathol; 1992 Sep; 141(3):721-7. PubMed ID: 1519673
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers.
Lin HJ; Lo WC; Perng CL; Li AF; Tseng GY; Sun IC; Ou YH
Helicobacter; 2004 Dec; 9(6):663-8. PubMed ID: 15610081
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and other gastric bacteria.
Varbanova M; Schulz C; Malfertheiner P
Dig Dis; 2011; 29(6):562-9. PubMed ID: 22179212
[TBL] [Abstract][Full Text] [Related]
8. Reduction of overall Helicobacter pylori colonization levels in the stomach of Mongolian gerbil by Lactobacillus johnsonii La1 (LC1) and its in vitro activities against H. pylori motility and adherence.
Isobe H; Nishiyama A; Takano T; Higuchi W; Nakagawa S; Taneike I; Fukushima Y; Yamamoto T
Biosci Biotechnol Biochem; 2012; 76(4):850-2. PubMed ID: 22484956
[TBL] [Abstract][Full Text] [Related]
9. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
11. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
Labenz J; Börsch G
Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
[TBL] [Abstract][Full Text] [Related]
12. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
13. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
Myllyluoma E; Veijola L; Ahlroos T; Tynkkynen S; Kankuri E; Vapaatalo H; Rautelin H; Korpela R
Aliment Pharmacol Ther; 2005 May; 21(10):1263-72. PubMed ID: 15882248
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of Helicobacter pylori infection: current status].
Wagner S; Gebel M; Manns M
Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
[TBL] [Abstract][Full Text] [Related]
15. The role of Helicobacter pylori in peptic ulcer disease.
O'Connor HJ
Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
[TBL] [Abstract][Full Text] [Related]
16. Probiotics in Helicobacter pylori-induced peptic ulcer disease.
Boltin D
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):99-109. PubMed ID: 27048901
[TBL] [Abstract][Full Text] [Related]
17. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics.
Arkkila PE; Kokkola A; Seppälä K; Sipponen P
Scand J Gastroenterol; 2007 Jun; 42(6):695-701. PubMed ID: 17505991
[TBL] [Abstract][Full Text] [Related]
18. [Coexistence of infection of the oral cavity and stomach and duodenal mucosa with Helicobacter pylori in patients with ulcer and chronic gastritis].
Kopaánski Z; Cienciala A; Banaś J; Kamiński B; Witkowska B; Zastepa P; Brandys J; Micherdziński J
Wien Klin Wochenschr; 1995; 107(7):219-24. PubMed ID: 7754615
[TBL] [Abstract][Full Text] [Related]
19. Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the BALB/c mouse.
Guo G; Jia KR; Shi Y; Liu XF; Liu KY; Qi W; Guo Y; Zhang WJ; Wang T; Xiao B; Zou QM
Stress; 2009 Nov; 12(6):478-85. PubMed ID: 20102319
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin.
Malekshahi ZV; Gargari SL; Rasooli I; Ebrahimizadeh W
Microb Pathog; 2011 Nov; 51(5):366-72. PubMed ID: 21803146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
